Back to search

Italy· 033190036

NEKACIN*1 fiala IM EV 1 g 4 ml

A amikacin product containing amikacina, registered in Italy by NEW RESEARCH Srl, on the national reimbursement list. The same ATC class is registered in 3 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC S01AA21

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedNEKACIN*1 fiala IM EV 1 g 4 mlATCS01AA21REGISTER NO.033190036PACKS LISTED1CHECKEDJune 4, 2026

Where it is registered

Amikacin is registered in 3 of 19 countries.

Countries holding a registration under ATC S01AA21 (amikacin), each read from that country’s own register.

  • This record: Italy
  • 2 of them publish a price we can compare per daily dose

Amikacin · ATC S01AA21

3 / 19 countries

  • Italyprice
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Active substance
Amikacina
Manufacturer
NEW RESEARCH Srl
Country
Italy (IT)
ATC code
S01AA21
ATC class
Amikacin
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    033190036
    NEKACIN*1 fiala IM EV 1 g 4 ml
    EUR 6.88

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Amikacin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All amikacin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Amikacin B. Braun
  • Belgium · Amikacine B. Braun, Amikacine Fresenius Kabi
  • Bulgaria · Amikacin Kabi, Амикацин Б. Браун
  • Cyprus · Amika-Synto, Amikacin Vioser
  • Czechia · Amikacin B. Braun, Amikacin Fresenius Kabi
  • Germany · Amikacin B. Braun, Amikacin Eberth
  • Denmark · Amikacin Afortas, Amikacin Macure
  • Estonia · Amikacin B. Braun
  • Spain · Amicacina, Amicacina B. Braun
  • Finland · Amikacin Afortas, Amikacin Macure
  • France · Amikacine B. Braun, Amikacine Kabi
  • United Kingdom (Northern Ireland) · Amikacin Demo Pharma Uk, Amikacin Galvany Pharma
  • Greece · Amicasil, Amikacin Anfarm
  • Croatia · Amikacin Zentiva
  • Hungary · Amikacin Anfarm, Amikacin B. Braun
  • Ireland · Amikacin, Amikacin Athlone Pharmaceuticals
  • Iceland · Arikayce Liposomal
  • Liechtenstein · Arikayce Liposomal
  • Lithuania · Biodacyna
  • Luxembourg · Amikacin B. Braun, Amukin
  • Latvia · Amikacin B.Braun
  • Malta · Amikacin Tillomed Laboratories, Uzix
  • Netherlands · Amikacine Hospira
  • Norway · Amikacin Afortas, Amikacin Macure
  • Poland · Amikacin B. Braun, Amikacin Kabi,
  • Portugal · Amicacina Hikma, Amicacina Kabi
  • Romania · Amikacin Noridem, Amikacină Atb
  • Sweden · Amikacin Afortas, Amikacin Fresenius Kabi
  • Slovenia · Amikacin Kabi
  • Slovakia · Amikacin B. Braun, Amikacin Fresenius Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/55a610c9-2fb1-4729-8dc2-d44a71183dbc
GET /v1/drugs/55a610c9-2fb1-4729-8dc2-d44a71183dbc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 6.88,
  "source": "aifa",
  "currency": "EUR",
  "strength": "AMIKACINA 1.000MG 1 UNITA' USO PARENTERALE",
  "substance": "Amikacina",
  "equivalence_group": "42D",
  "transparency_flag": "X"
}

See everything about amikacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.